This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Thomas S Suhar: Innovator in Hepatitis C Research
Introduction
Thomas S Suhar is a notable inventor based in Lindenhurst, IL (US). He has made significant contributions to the field of virology, particularly in the study of the Hepatitis C virus. His innovative work has led to advancements in the expression of viral proteins, which are crucial for research and therapeutic development.
Latest Patents
Thomas S Suhar holds 1 patent for his invention titled "Hepatitis C virus second envelope (HCV-E2) glycoprotein expression system." This invention provides a novel mammalian expression system capable of generating high levels of expressed hepatitis C virus (HCV) proteins, which have previously proved difficult to express due to their non-secretory properties. The invention includes a plasmid for the expression of the HCV second envelope protein (E2), designated p577. This plasmid encodes a recombinant protein comprising the immunoglobulin signal peptide and amino acids 388-664 of the HCV E2 glycoprotein. This unique expression system produces high levels of HCV proteins that are properly processed, glycosylated, and folded.
Career Highlights
Thomas S Suhar is associated with Abbott Laboratories Corporation, a leading global healthcare company. His work at Abbott has focused on developing innovative solutions for complex health challenges, particularly in the area of infectious diseases.
Collaborations
Throughout his career, Thomas has collaborated with notable colleagues, including Gregory F Okasinski and Verlyn G Schaefer. These collaborations have contributed to the advancement of research in the field of virology and the development of effective treatments.
Conclusion
Thomas S Suhar's contributions to the field of Hepatitis C research through his innovative expression system have the potential to significantly impact the understanding and treatment of this viral infection. His work exemplifies the importance of innovation in addressing global health challenges.